《新股消息》GHW INTL(09933.HK)今日起招股 入場費約2,626元
應用化學中間體供應商GHW INTL(09933.HK)公布於本港上市計劃,全球發售2.5億股,其中10%於本港公開發售,招股價介乎0.51元至0.65元,每手4,000股,入場費2,626.2元。今日起招股,下週五(10日)截止,預期於同日定價,1月21日上市。
是次上市獨家保薦人為富強金融資本,聯席全球協調人為富強證券及聯合證券;聯席賬簿管理人及聯席牽頭經辦人為富強證券、聯合證券、一盈證券、浦銀國際及第一上海;共同牽頭經辦人為阿爾法國際證券、中新證券、Standard Perpetual及利弗莫爾證券。
以招股價中位數0.58元計,公司預計上市集資淨額9,630萬元,其中17.2%擬用於成立初期的新生產廠房,60.4%擬用於在新生產廠房建設生產三甲胺的生產設施,10.2%擬用於在新生產廠房建設小批生產不同類型醫藥中間體的試驗廠房,2.2%擬用於新醫藥產品鹽酸莫西沙星片的研發,0.8%擬用於採購硬件及軟件以升級財務及會計管理系統,其餘9.2%擬用於作營運資金及其他一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.